DiscoverTrends from the TrenchesEpisode: 5 - Kim Branson on Building Groundbreaking AI/ML Models in Drug Discovery
Episode: 5 - Kim Branson on Building Groundbreaking AI/ML Models in Drug Discovery

Episode: 5 - Kim Branson on Building Groundbreaking AI/ML Models in Drug Discovery

Update: 2022-05-24
Share

Description

Dr. Kim Branson’s intense interest in drug discovery and structural biology quickly led to an interest in machine learning. After receiving multiple degrees from esteemed universities in Australia, Branson trained at Stanford and now works as the Senior Vice President and Global Head of AI/ML at GSK. With host, Stan Gloss, Branson shares his work in creating “biological twins.” These 3-D tumor culture models replicate cancer and their respective immune environments. Branson and his team monitor tumor and immune responses to cancer drugs in real-time. The clinical implications of anticipating a tumor’s every move within a patient’s body are astounding. He also explains why thoughtfulness is paramount in experiment design and how a project’s impact should be the primary consideration before proceeding. Learn how GSK recruits talent and the importance of creating a multidisciplinary environment. Hear Branson talk about eliminating AI analysis bias, navigating ethical issues, and the new generation of leaders on his team. 

Links from this episode:  
Bio-IT World
BioTeam
GSK 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode: 5 - Kim Branson on Building Groundbreaking AI/ML Models in Drug Discovery

Episode: 5 - Kim Branson on Building Groundbreaking AI/ML Models in Drug Discovery

Bio-IT World